Literature DB >> 19731200

Matrix metalloproteinase gene polymorphisms: lack of association with chronic obstructive pulmonary disease in a Brazilian population.

H Schirmer1, L Basso da Silva, P J Z Teixeira, J S Moreira, A L S Moreira, D Simon.   

Abstract

There are many candidate genes for chronic obstructive pulmonary disease (COPD). One such candidate is the group of genes that code for matrix metalloproteinases (MMPs), which play an essential role in tissue remodeling and repair associated with COPD. We tested the hypothesis that polymorphic variation in MMP genes influences the risk of developing COPD by examining functional polymorphisms in the promoters of MMP-3, MMP-9 and MMP-12 genes in 111 COPD patients and 101 controls. The -1171 5A/6A MMP-3, -1562 C/T MMP-9 and -82 A/G MMP-12 polymorphisms were analyzed by polymerase chain reaction, followed by restriction digestion. No significant differences were observed in allele and genotype frequencies between COPD patients and controls. Haplotype analysis also did not reveal differences between COPD patients and controls. We found that MMP polymorphisms had no significant impact on the risk of developing COPD in this Brazilian sample.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19731200     DOI: 10.4238/vol8-3gmr596

Source DB:  PubMed          Journal:  Genet Mol Res        ISSN: 1676-5680


  9 in total

Review 1.  Fibrotic response of tissue remodeling in COPD.

Authors:  Lina María Salazar; Ana Milena Herrera
Journal:  Lung       Date:  2011-02-02       Impact factor: 2.584

2.  Matrix Metalloproteinase-9 (279R/Q) Polymorphism is Associated with Clinical Severity and Airflow Limitation in Tunisian Patients with Chronic Obstructive Pulmonary Disease.

Authors:  Sarra Bchir; Hela Ben Nasr; Imen Rekik Hakim; Amel Ben Anes; Saloua Yacoub; Abdelhamid Garrouch; Mohamed Benzarti; Brigitte Bauvois; Zouhair Tabka; Karim Chahed
Journal:  Mol Diagn Ther       Date:  2015-12       Impact factor: 4.074

3.  Relationships of COX2 and MMP12 genetic polymorphisms with chronic obstructive pulmonary disease risk: a meta-analysis.

Authors:  Xiao-Ling Yu; Jun Zhang; Fei Zhao; Xiao-Ming Pan
Journal:  Mol Biol Rep       Date:  2014-09-11       Impact factor: 2.316

Review 4.  Updates on the COPD gene list.

Authors:  Yohan Bossé
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2012-09-18

5.  The selected genetic polymorphisms of metalloproteinases MMP2, 7, 9 and MMP inhibitor TIMP2 in sarcoidosis.

Authors:  Wojciech J Piotrowski; Paweł Górski; Tadeusz Pietras; Wojciech Fendler; Janusz Szemraj
Journal:  Med Sci Monit       Date:  2011-10

6.  Association of MMP-2 polymorphisms with severe and very severe COPD: a case control study of MMPs-1, 9 and 12 in a European population.

Authors:  Imran Haq; Sally Chappell; Simon R Johnson; Juzer Lotya; Leslie Daly; Kevin Morgan; Tamar Guetta-Baranes; Josep Roca; Roberto Rabinovich; Ann B Millar; Seamas C Donnelly; Vera Keatings; William MacNee; Jan Stolk; Pieter S Hiemstra; Massimo Miniati; Simonetta Monti; Clare M O'Connor; Noor Kalsheker
Journal:  BMC Med Genet       Date:  2010-01-15       Impact factor: 2.103

7.  Matrix metalloproteinase-9 -1562C/T promoter polymorphism confers risk for COPD: a meta-analysis.

Authors:  Lei Chen; Tao Wang; Lian Liu; Yongchun Shen; Chun Wan; Fuqiang Wen
Journal:  PLoS One       Date:  2013-03-28       Impact factor: 3.240

8.  Genetic polymorphism of matrix metalloproteinase family and chronic obstructive pulmonary disease susceptibility: a meta-analysis.

Authors:  Hongbin Zhou; Yinfang Wu; Yan Jin; Jiesen Zhou; Chao Zhang; Luanqing Che; Jiyong Jing; Zhihua Chen; Wen Li; Huahao Shen
Journal:  Sci Rep       Date:  2013-10-02       Impact factor: 4.379

9.  MMP-9-C1562T polymorphism and susceptibility to chronic obstructive pulmonary disease: A meta-analysis.

Authors:  Rongrong Zhao; Houxiu Zhou; Jingci Zhu
Journal:  Medicine (Baltimore)       Date:  2020-07-31       Impact factor: 1.817

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.